Navigation Links
IVI announces the prequalification of innovative cholera vaccine by the World Health Organization
Date:11/11/2011

Institute of Hygiene and Epidemiology and production experts at Shantha, IVI enabled technology transfer from Vabiotech, a vaccine manufacturer in Vietnam, to Shantha for the production of cholera vaccine. IVI also established and transferred tests to ensure the vaccine was of the highest quality and enabled improvements in production to keep manufacturing costs as low as possible.

"This important milestone validates Vabiotech's efforts and technical capability in developing and promoting the manufacture of an affordable cholera vaccine for the world's poorest people," said Dr. Nguyen Thu Van, Director General of Vabiotech. "We are eager to see this vaccine rapidly deployed, especially in endemic areas, amid recent outbreaks of cholera in Africa, Asia and the Caribbean."

A Phase III clinical trial performed by IVI and colleagues at India's National Institute of Cholera and Enteric Diseases was launched at a field site in Kolkata to evaluate the vaccine in people from ages one year and up. The results showed the vaccine to be safe and protective against cholera for three years in all age groups. Licensed in India in 2009, Shanchol was the first vaccine to be developed and licensed from the pipeline of vaccines being developed with support from the Bill & Melinda Gates Foundation

"Prequalification of the Shanchol vaccine by WHO represents a validation of Shantha's quality processes and the safety and efficacy of the vaccine," said Dr. Harish Iyer, Chief Executive Officer of Shantha Biotechnics. "This approval also reinforces our commitment to work with partners to provide vaccines against infectious diseases affecting developing countries."

The prequalification by WHO sets the stage for IVI's next planned phase of the vaccine, which is introducing Shanchol in countries where cholera remains a major public health problem, such as countries in Africa and South Asia where the disease is endemic. Recently IVI estimated that nearly
'/>"/>

Contact: Tae Kyung Byun
tkbyun@ivi.int
82-119-773-6071
International Vaccine Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. AMRI announces collaboration agreement with Lilly for in-sourced chemistry services
2. University of Michigan announces Eric J. Topol Professorship in Cardiovascular Medicine
3. Peter Thiel announces Breakout Labs to energize innovation
4. ESC announces review of Atrial Fibrillation Guidelines
5. The Waxman Foundation announces $25,000 grant in B-cell lymphoma research
6. INFORMS journal announces special issue on using logistics, analytics in humanitarian relief
7. ASTRO announces 2011 Fellows class
8. The New York Stem Cell Foundation announces new initiative for Parkinsons disease
9. AFAR announces the 2011 Hartford Scholars in Geriatric Medicine
10. AGA announces prestigious recognition award recipients
11. Sanofi Pasteur announces FDA approval of menactra meningococcal conjugate vaccine indication for infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Bellingham, Washington (PRWEB) June 19, 2013 ... before physicians deem it medically necessary, according to ... Maternal and Child Health Journal. The results of ... advocating for more than a decade – that ... care, and maintaining a healthy body weight. Fairhaven ...
(Date:6/19/2013)... Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig,s ... be classified into four distinct stages, report pathologists with ... Pennsylvania in the Annals of Neurology . This ... shows, for the first time, how the fatal degenerative ... central nervous system to other regions of brain and ...
(Date:6/19/2013)... Amsterdam, June 19, 2013 Elsevier, a world-leading ... and services, announced today the publication of the ... diagnosis and management of osteoporosis in postmenopausal women ... . , Published in 2009 in Maturitas ... and this update is timely with an additional ...
(Date:6/19/2013)... The former internist for the St. Louis Rams ... as director of prevention and wellness at St. Luke’s ... encounter with a metabolic syndrome diagnosis and a happenstance ... that he credits with sparking the paradigm-shift that has ... , “The average medical student gets 30 minutes of ...
(Date:6/19/2013)... 19, 2013 Recently, SoCal CEO Magazine ... held their third in a series of six workshops where ... Respect and helped place the mosaic tiles in their permanent location ... parents, Cathy and Greg Maxwell. , This mural project began ... that took root over three years ago with the goal ...
Breaking Medicine News(10 mins):Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 2Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 3Health News:Arc Creates Huge Mosaic Mural to Highlight the Need for Greater Respect of People with Disabilities 2
... An Annualized Yield Of 9.5%, LARGO, Fla., Feb. ... (TSX Venture Exchange: UVI) Board of Directors,today declared its ... payable February 28, 2008 to stockholders of record at ... are pleased to continue the quarterly dividend policy which ...
... start in two years, California researcher says , , FRIDAY, Feb. ... stopped the progress of the disease in 90 percent of ... vaccine turned the cancer into a chronic, manageable disease," said ... the Feb. 1 issue of Cancer Research . , ...
... The globally active precious,metal and technology group Heraeus ... Interventional Business of Synovis Life,Technologies, Inc., based in ... 31, 2008. With this acquisition, the Heraeus Medical,Components ... facilities in the,U.S., Germany, Switzerland and Puerto Rico., ...
... Feb. 1 Lifespring Health,sponsors the Kaiser Permanente San ... important charity event benefiting the Hemophilia Foundation of,Northern California, ... Family House., Set to take place on Feb. ... mile course is ranked as one of the most ...
... Brian Piwek to Assist in Generating New Retail ... Skinvisible, Inc. (OTC,Bulletin Board: SKVI) ( http://www.skinvisible.com ), ... of patented dermatology,products with their proprietary polymer delivery ... been selected as a new member of,the Company,s ...
... In healthy people, both sleepiness and vigilance show a ... When core body temperature is high during the daytime, ... Conversely, when core body temperature is low at ... optimal sleep. Among those suffering from narcolepsy, however, ...
Cached Medicine News:Health News:Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share 2Health News:Experimental Vaccine Halts Prostate Cancer in Mice 2Health News:Experimental Vaccine Halts Prostate Cancer in Mice 3Health News:Heraeus Strengthens Medical Components Business 2Health News:Skinvisible Appoints New Board Member 2Health News:Skinvisible Appoints New Board Member 3Health News:Changes in narcoleptics' skin, core body temperatures affect their vigilance and sleepiness 2Health News:Changes in narcoleptics' skin, core body temperatures affect their vigilance and sleepiness 3
(Date:6/19/2013)... Amerivet Solutions, LLC ( AMERIVET ), ... government from Federal to Municipal, is pleased to ... include complex metal design and fabrication manufacturing. "We ... aluminum parts for the Defense Logistics Agency (DLA) ... service government contracts," states Richard Bergen , ...
(Date:6/19/2013)... 2013 DST Health Solutions, LLC (DSTHS), a ... plans, integrated delivery systems, and health care providers, has ... Service (MDMS) has jumped significantly. A ... pricing of medical prescription drug claims, MDMS ... medical drug claims processes. As specialty drug demand grows ...
(Date:6/19/2013)... 19, 2013 /PRNewswire-iReach/ -- Today leading web researchers Change ... ranking Pharmaceutical web sites for usability, engagement, and conversion. ... Cloud platform, which compares how people experience sites with ... The top three performers are easier to ... The bottom performers have usability problems, lack aspects of ...
Breaking Medicine Technology:Amerivet Solutions Expands to Manufacture Complex Metal Designs 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2
... Cellular Dynamics International, Inc. (CDI) today announced ... will distribute CDI,s iCell® Cardiomyocytes , the first commercially ... Japan. This distribution agreement brings the vision ... Thomson and Dr. Shinya Yamanaka , a step ...
... StreamVenue Healthcare has partnered its "plug and play" ... Medicine to teach, and to better manage post-surgical patient ... surgeons and physical therapists to view cases and discuss ... cohesive communication and creates a live classroom for teaching ...
Cached Medicine Technology:iPS Academia Japan, Inc. to Distribute Cellular Dynamics' iCell® Products in Japan 2iPS Academia Japan, Inc. to Distribute Cellular Dynamics' iCell® Products in Japan 3StreamVenue Healthcare Connects Endoscopy Technology With Athletic Trainers 2
The MESACUP ANA Test Kit is a semi-quantitative enzyme-linked immunosorbent assay,(ELISA) for the detection of specific anti-nuclear antibodies in human serum as an aid in,the determination of autoim...
... HEp-2 cell line that has been genetically ... autoantibodies, without affecting the other ANA patterns ... worldwide on the HEp-2000 ANA substrate, which ... used in place of standard HEp-2 cells ...
... assays can be used to screen ... which are associated with various systemic ... erythematosus (Lupus), Sjgren's syndrome, mixed connective ... polymyositis, dermatomyositis, and Raynaud's phenomenon. They ...
... assays can be used to screen ... which are associated with various systemic ... erythematosus (Lupus), Sjgren's syndrome, mixed connective ... polymyositis, dermatomyositis, and Raynaud's phenomenon. They ...
Medicine Products: